Page last updated: 2024-08-26

yttrium radioisotopes and Cutaneous T-Cell Lymphoma

yttrium radioisotopes has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boland, C; Brown, MR; Carrasquillo, JA; Fleisher, TA; Foss, FM; Frincke, JM; Larson, SM; Lollo, CP; Mulshine, JL; Neumann, RD; Paik, CH; Perentesis, P; Raubitscheck, A; Reynolds, JC1

Trials

1 trial(s) available for yttrium radioisotopes and Cutaneous T-Cell Lymphoma

ArticleYear
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:11

    Topics: Adult; Antibodies, Monoclonal; CD5 Antigens; Humans; Immunoconjugates; Indium Radioisotopes; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Lymphoma, T-Cell, Cutaneous; Middle Aged; Radioimmunotherapy; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes

1998